SEATTLE — In this Healio Video Perspective from the ARVO meeting, Allen C. Ho, MD, FASRS, discusses 12-month data on MCO-010 optogenetic therapy for patients with retinitis pigmentosa.According to Ho, patients who received high- and low-dose MCO-010 (N…
Revamped Antibiotic May Treat Deadly Eye Infection
Topical cefiderocol “could be a new weapon in the ophthalmologist’s arsenal” to combat a strain of bacteria found last year in bottles of artificial tears, researchers report at ARVO 2024. Medscape Medical News
VIDEO: Dry eye supplement improves disease severity, tear volume across two studies
SEATTLE — In this Healio Video Perspective from the ARVO meeting, Neda Gioia, OD, CNS, FOWNS, discusses two studies investigating a novel oral supplement for patients with dry eye disease from Bausch + Lomb.The primary efficacy outcomes of the studies …
STAAR Surgical Reports First Quarter 2024 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: K), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial resul…
STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announces another mil…
VIDEO: Blink Triple Care drop shows good comfort, vision improvements for dry eye
SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.According to Donnenfeld, Blink Triple Care drops (Bau…